Paper Review Records
All Paper Review Records
24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Dexmedetomidine Use in Adverse Radiation Effect Presenting as Refractory Status Dystonicus
Abena Odurowaa Yeboah; Anna Derman; Bernadine Donahue; Benjamin Cooper; Justin Rice; Mahmut Y. ÇelikerShow moreShow less
1. Department of Pediatrics Maimonides Children's Hospital Brooklyn New York USA; 2. Department of Radiology Maimonides Medical Center Brooklyn New York USA; 3. Department of Radiation Oncology Maimonides Medical Center Brooklyn New York USA; 4. Department of Radiation Oncology NYU Grossman School of Medicine New York New York USA; 5. Division of Palliative Medicine Department of Medicine Maimonides Medical Center Brooklyn New York USA; 6. Division of Pediatric Hematology Oncology Department of Pediatrics Maimonides Children's Hospital Brooklyn New York USAShow moreShow less
Chylous Malignant Pleural Effusion in High‐Risk Metastatic Neuroblastoma: A Rare Presentation and Management Challenge
Saif Aldeen Rawabdeh; Sara Omar Abualeenein; Faten Awwad; Lama Bani Salameh; Bassem Bataineh; Suleimman Al‐SweedanShow moreShow less
1. Department of Pediatrics Faculty of Medicine Jordan University of Science and Technology Irbid Jordan; 2. Department of Medicine Faculty of Medicine Jordan University of Science and Technology Irbid Jordan; 3. Department of General Surgery and Urology, Pediatric Surgery Section Jordan University of Science and Technology Irbid Jordan; 4. Department of Pediatric Hematology/Oncology/BMT, King Abdullah University Hospital Faculty of Medicine Jordan University of Science and Technology, Ar Ramtha Irbid JordanShow moreShow less
Trametinib in Neurofibromatosis Type 1‐Associated Plexiform Neurofibroma—Real‐World Data From the SACHA‐France Study
Clara Rigaud Vanderkelen; Isabelle Aerts; François Sevrin; Lee Aymar Ndounga‐Diakou; Samuel Abbou; Yves Reguerre; Natacha Entz‐Werle; Camille Khanfar; Pierre Leblond; Cécile Faure‐Conter; Liana Carausu; Stéphane Ducassou; Claire Freycon; Anne Pagnier; Gilles Vassal; Pablo Berlanga; Nicolas AndreShow moreShow less
1. Department of Pediatric Onco‐Immuno‐Hematology Timone University Hospital AP‐HM Marseille France; 2. SIREDO Oncology Center (Care, Innovation and Research for Children and AYA With Cancer); RTOP (Recherche Translationnelle en Oncologie Pédiatrique) U830 INSERM Institut Curie PSL Research University Paris France; 3. Department of Pediatric Oncology Oscar Lambret Center Lille France; 4. Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus Université Paris‐Saclay Villejuif France; 5. Department of Pediatric and Adolescent Oncology Gustave Roussy Comprehensive Cancer Center and Paris Saclay University Villejuif France; 6. Department of Pediatric Oncology and Hematology University Hospital of Saint Denis De La Réunion Saint‐Denis France; 7. EN‐HOPE SMART4CBT Research Center PEDIACRIEX University Hospital of Strasbourg Lille, Nancy, Strasbourg France; 8. Pediatric Onco‐Hematology Unit University Hospital of Strasbourg Strasbourg France; 9. Department of Pediatric Oncology University Hospital of Amiens Picardie Amiens France; 10. Institute of Pediatric Hematology and Oncology (iHOPe), Leon Berard Center Lyon France; 11. Department of Pediatric Hematology and Oncology CHU de Brest Brest France; 12. Department of Pediatric Hematology and Oncology University Hospital of Bordeaux Bordeaux France; 13. Department of Pediatric Onco‐Immuno‐Hematology Grenoble Alpes University Hospital Grenoble France; 14. UMR INSERM 1068, CNRS UMR 7258, Aix Marseille University U105, Marseille Cancer Research Center (CRCM) Marseille FranceShow moreShow less
Caregiver Primary Language and Barriers to Care at Diagnosis of Pediatric Acute Leukemia
Maria D. Gonzalez Hinojosa; Chynna M. Swift; Jacklyn Sanchez Alvarez; Anthony Bell; Maria I. Castellanos; Michael Seid; Lena E. WinestoneShow moreShow less
1. School of Medicine University of California San Francisco California USA; 2. Division of Oncology Department of Pediatrics UCSF Benioff Children's Hospitals San Francisco California USA; 3. UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California USA; 4. Department of Pediatrics College of Medicine University of Cincinnati Cincinnati Ohio USA; 5. James M. Anderson Center for Health Systems Excellence Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA; 6. Division of Pulmonary Medicine Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA; 7. Division of Allergy Immunology, and Blood & Marrow Transplant Department of Pediatrics UCSF Benioff Children's Hospitals San Francisco California USAShow moreShow less
Preserved Right Ventricular Function With Early Remodeling in Pediatric Sickle Cell Disease: Comprehensive Echocardiographic Assessment and Longitudinal Analysis
Theresia Tannoury; Rana Zareef; Hani Tamim; Maha Makki; Fadi F. Bitar; Ziad Bulbul; Miguel R. Abboud; Nabil Kabbara; Aya El TraboulsiShow moreShow less
1. Department of Pediatrics and Adolescent Medicine American University of Beirut Medical Center Beirut Lebanon; 2. Clinical Research Institute American University of Beirut Medical Center Beirut Lebanon; 3. College of Medicine Alfaisal University Riyadh Saudi Arabia; 4. Pediatric Hematology‐Oncology Division New Mazloum Hospital Tripoli Lebanon; 5. Pediatric Hematology‐Oncology Division Haykel Hospital Tripoli LebanonShow moreShow less
Prevalence of Iron Deficiency Among a Modern Cohort of Youth With Sickle Cell Disease
Anyssa N. Young; Brett G. Klamer; Amanda Jacobson‐Kelly; Sapuni S. Chandrasena; Sara Conroy; Hollie M. Reeves; Susan E. CrearyShow moreShow less
1. Abigail Wexner Research Institute, Nationwide Children's Hospital Columbus Ohio USA; 2. Biostatistics Resource at Nationwide Children's Hospital, Abigail Wexner Research Institute, Nationwide Children's Hospital Columbus Ohio USA; 3. Center For Biostatistics The Ohio State University Wexner Medical Center Columbus Ohio USA; 4. Department of Hematology, Oncology, and Bone Marrow Transplant Nationwide Children's Hospital Columbus Ohio USA; 5. Department of Pathology Nationwide Children's Hospital Columbus Ohio USAShow moreShow less
FAQ
How long does PEDIATRIC BLOOD & CANCER take to review a manuscript?
As of 2026-11-17, CrushSCI has 24 complete review records for PEDIATRIC BLOOD & CANCER. The fastest paper went from submission to acceptance in 6 days (Fatal Neuroinvasive Astrovirus VA1 Encephalitis in a Child With High‐Risk B‐ALL Receiving Blinatumomab, received 2026-07-29, accepted 2026-08-04); the slowest took 244 days. The average is 92.0 days and the median is 71.5 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
